Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (25) 25
life sciences & biomedicine (24) 24
humans (16) 16
hematology (14) 14
cardiovascular system & cardiology (11) 11
male (10) 10
female (9) 9
von willebrand factor (9) 9
cardiac & cardiovascular systems (8) 8
peripheral vascular disease (8) 8
abridged index medicus (6) 6
aged (6) 6
atherosclerosis (6) 6
biomarkers - blood (6) 6
aged, 80 and over (5) 5
middle aged (5) 5
patients (5) 5
tissue factor (5) 5
animals (4) 4
coagulation (4) 4
hemophilia (4) 4
medicine, research & experimental (4) 4
research & experimental medicine (4) 4
risk factors (4) 4
analysis (3) 3
biomarkers (3) 3
cardiovascular (3) 3
case-control studies (3) 3
cells, cultured (3) 3
coagulation factors (3) 3
covid-19 (3) 3
factor viii (3) 3
health aspects (3) 3
human health and pathology (3) 3
life sciences (3) 3
medicine (3) 3
pharmacokinetics (3) 3
rabbits (3) 3
thromboplastin - metabolism (3) 3
transcatheter aortic valve replacement (3) 3
treatment outcome (3) 3
von willebrand factor - chemistry (3) 3
von willebrand factor - metabolism (3) 3
adult (2) 2
algorithms (2) 2
angioplasty, balloon (2) 2
antifibrinolytic agents - administration & dosage (2) 2
antifibrinolytic agents - adverse effects (2) 2
antifibrinolytic agents - pharmacokinetics (2) 2
aorta (2) 2
aortic stenosis (2) 2
aortic valve - surgery (2) 2
aortic valve insufficiency - blood (2) 2
aortic valve stenosis (2) 2
aortic valve stenosis - physiopathology (2) 2
aortic valve stenosis - surgery (2) 2
atherosclerosis - metabolism (2) 2
betacoronavirus - isolation & purification (2) 2
biological and medical sciences (2) 2
bleeding (2) 2
blood (2) 2
blood and lymphatic vessels (2) 2
blood loss, surgical - prevention & control (2) 2
body mass index (2) 2
cardiology and cardiovascular medicine (2) 2
cardiology. vascular system (2) 2
cesarean section (2) 2
cesarean section - adverse effects (2) 2
clotting (2) 2
collagen (2) 2
congenital diseases (2) 2
coronary vessels (2) 2
coronavirus infections - complications (2) 2
d-dimers (2) 2
defects (2) 2
disease models, animal (2) 2
dosage and administration (2) 2
double-blind method (2) 2
drug dosage calculations (2) 2
drug monitoring - methods (2) 2
fibrinolysin - metabolism (2) 2
fibrinolysis (2) 2
fibrinolysis - drug effects (2) 2
france (2) 2
genetic aspects (2) 2
genotype (2) 2
heart-assist devices - adverse effects (2) 2
immunohistochemistry (2) 2
medical laboratory technology (2) 2
medical research (2) 2
medical sciences (2) 2
medicine, experimental (2) 2
mortality (2) 2
multicenter studies as topic (2) 2
original (2) 2
pandemics (2) 2
pathology (2) 2
phenotype (2) 2
plasma - metabolism (2) 2
plasmin (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Assessment of primary haemostasis with a new recombinant von Willebrand factor in patients with von Willebrand disease
by Trossaërt, Marc and Flaujac, Claire and Jeanpierre, Emmanuelle and Drillaud, Nicolas and Sigaud, Marianne and Fouassier, Marc and Ternisien, Catherine and de Raucourt, Emmanuelle
Haemophilia : the official journal of the World Federation of Hemophilia, ISSN 1351-8216, 03/2020, Volume 26, Issue 2, pp. e44 - e48
Life Sciences & Biomedicine | Hematology | Science & Technology | Von Willebrand factor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Risk of Pulmonary Embolism More Than 6 Weeks After Surgery Among Cancer-Free Middle-aged Patients
by Caron, Alexandre and Depas, Nicolas and Chazard, Emmanuel and Yelnik, Cecile and Jeanpierre, Emmanuelle and Paris, Camille and Beuscart, Jean-Baptiste and Ficheur, Gregoire
JAMA surgery, ISSN 2168-6254, 12/2019, Volume 154, Issue 12, pp. 1126 - 1132
Life Sciences & Biomedicine | Surgery | Science & Technology
Journal Article
Details down arrow
3. Full Text Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support
by Vincent, Flavien and Rauch, Antoine and Loobuyck, Valentin and Robin, Emmanuel and Nix, Christoph and Vincentelli, André and Smadja, David M and Leprince, Pascal and Amour, Julien and Lemesle, Gilles and Spillemaeker, Hugues and Debry, Nicolas and Latremouille, Christian and Jansen, Piet and Capel, Antoine and Moussa, Mouhamed and Rousse, Natacha and Schurtz, Guillaume and Delhaye, Cédric and Paris, Camille and Jeanpierre, Emmanuelle and Dupont, Annabelle and Corseaux, Delphine and Rosa, Mickaël and Sottejeau, Yoann and Barth, Svenja and Mourran, Claudia and Gomane, Valérie and Coisne, Augustin and Richardson, Marjorie and Caron, Claudine and Preda, Cristian and Ung, Alexandre and Carpentier, Alain and Hubert, Thomas and Denis, Cécile and Staels, Bart and Lenting, Peter J and Van Belle, Eric and Susen, Sophie
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2018, Volume 71, Issue 19, pp. 2106 - 2118
mechanical circulatory support | extracorporeal membrane oxygenation | bleeding | blood flow | arterial pulsatility | von Willebrand factor | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Extracorporeal Circulation - adverse effects | Heart-Assist Devices - trends | Shock, Cardiogenic - therapy | Humans | Middle Aged | Stress, Mechanical | Male | Heart-Assist Devices - adverse effects | Arterial Pressure - physiology | Biomarkers - blood | Shock, Cardiogenic - physiopathology | Animals | Pulsatile Flow - physiology | Swine | Extracorporeal Circulation - trends | Shock, Cardiogenic - blood | von Willebrand Factor - metabolism | Heart | Animal models | Preservation | Patients | Bleeding | Risk factors | Defects | Degradation | Studies | Algorithms | Restoration | Proteolysis | Coronary vessels | Von Willebrand factor | Shear stress | Cardiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. von Willebrand Factor and Management of Heart Valve Disease JACC Review Topic of the Week
by Van Belle, Eric and Vincent, Flavien and Rauch, Antoine and Casari, Catarina and Jeanpierre, Emmanuelle and Loobuyck, Valentin and Rosa, Mickael and Delhaye, Cedric and Spillemaeker, Hughes and Paris, Camille and Debry, Nicolas and Verdier, Basile and Vincentelli, Andre and Dupont, Annabelle and Lenting, Peter J and Susen, Sophie
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2019, Volume 73, Issue 9, pp. 1078 - 1088
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Heart Valve Diseases - blood | Severity of Illness Index | Clinical Decision-Making | Humans | Heart Valve Prosthesis Implantation - methods | Disease Management | Heart Valve Diseases - surgery | Biomarkers - blood | von Willebrand Factor - metabolism | Evaluation | Congenital diseases | Complications | Decision making | Therapeutic applications | Mortality | Cardiovascular disease | Disease control | Coronary artery disease | Heart valves | Bleeding | Defects | Blood platelets | Collagen | Surgery | Von Willebrand factor | Biomarkers | Hemodynamics | Rheumatic heart disease | Heart diseases
Journal Article
Details down arrow
5. Full Text Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals)
by Nougier, Christophe and Jeanpierre, Emmanuelle and Ternisien, Catherine and Proulle, Valérie and Hezard, Nathalie and Pouplard, Claire and Lasne, Dominique and Working Grp Biol Haemorrhagic and With contributions from the Working Group on Biology of Haemorrhagic Disorders (BIMHO, Under the Aegis of GFHT)
European journal of haematology, ISSN 0902-4441, 12/2020, Volume 105, Issue 6, pp. 675 - 681
emicizumab | haemophilia | coagulation assay | Life Sciences & Biomedicine | Hematology | Science & Technology | Thromboplastin | Monoclonal antibodies | Patients | Hemophilia | Coagulation | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID‐19
by Rauch, Antoine and Labreuche, Julien and Lassalle, Fanny and Goutay, Julien and Caplan, Morgan and Charbonnier, Leslie and Rohn, Aurelien and Jeanpierre, Emmanuelle and Dupont, Annabelle and Duhamel, Alain and Faure, Karine and Lambert, Marc and Kipnis, Eric and Garrigue, Delphine and Lenting, Peter J and Poissy, Julien and Susen, Sophie
Journal of thrombosis and haemostasis, ISSN 1538-7933, 11/2020, Volume 18, Issue 11, pp. 2942 - 2953
factor VIII | oxygen | body mass index | SARS‐CoV2 | von Willebrand factor | SARS-CoV2 | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Factor VIII - analysis | Prevalence | Prospective Studies | Age Factors | Humans | Middle Aged | Patient Admission | Male | COVID-19 - diagnosis | Venous Thromboembolism - blood | Venous Thromboembolism - prevention & control | COVID-19 - blood | Female | Thrombosis - blood | Thrombosis - prevention & control | COVID-19 - epidemiology | Venous Thromboembolism - epidemiology | Venous Thromboembolism - diagnosis | von Willebrand Factor - analysis | France - epidemiology | Risk Assessment | Comorbidity | Risk Factors | Anticoagulants - therapeutic use | Thrombosis - epidemiology | Treatment Outcome | Biomarkers - blood | Oxygen Inhalation Therapy | COVID-19 - therapy | Blood Coagulation - drug effects | Sex Factors | Thrombosis - diagnosis | Hypertension | Oxygen | Diabetes mellitus | Coagulation | Regression analysis | Leukocytes | Metabolic syndrome | Thrombosis | Thromboplastin | Coagulation factors | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Body mass index | Von Willebrand factor | Fibrinogen | Prothrombin | Biomarkers | Diabetes | Platelets | Age | Metabolic disorders | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence
by Poissy, Julien and Goutay, Julien and Caplan, Morgan and Parmentier, Erika and Duburcq, Thibault and Lassalle, Fanny and Jeanpierre, Emmanuelle and Rauch, Antoine and Labreuche, Julien and Susen, Sophie and Lille ICU Haemostasis COVID-19 Group
Circulation (New York, N.Y.), ISSN 0009-7322, 07/2020, Volume 142, Issue 2, pp. 184 - 186
COVID-19 | thrombosis | body mass index | von Willebrand factor | D-dimer | pulmonary embolism | factor VIII | Pandemics | Prevalence | Prognosis | Humans | Middle Aged | Male | Pulmonary Embolism - epidemiology | SARS-CoV-2 | Fibrinolytic Agents - therapeutic use | Pneumonia, Viral - complications | Aged, 80 and over | Coronavirus Infections - complications | Adult | Female | Length of Stay | Pulmonary Embolism - complications | Intensive Care Units | Tertiary Care Centers | Betacoronavirus - isolation & purification | Coronavirus Infections - diagnosis | Risk Factors | Pulmonary Embolism - diagnosis | Pneumonia, Viral - diagnosis | Pulmonary Embolism - drug therapy | Aged | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Multicentre pharmacokinetic evaluation of rFVIII‐Fc (efmoroctocog alfa) in a real life and comparison with non‐extended half‐life FVIII concentrates
by Pouplard, Claire and Sattler, Laurent and Ryman, Anne and Eschwege, Valérie and De Maistre, Emmanuel and Flaujac, Claire and Szymezak, Jean and Grand, François and Repesse, Yohann and Galinat, Hubert and Donnard, Magali and Ternisien, Catherine and Iorio, Alfonso and Chelle, Pierre and Jeanpierre, Emmanuelle and Biol Study Grp Haemorrhagic Dis Gr and ‘Biology Study Group on Haemorrhagic Diseases’ (Group BIMHO - GFHT) and On behalf of the ‘Biology Study Group on Haemorrhagic Diseases’ (Group BIMHO ‐ GFHT)
Haemophilia : the official journal of the World Federation of Hemophilia, ISSN 1351-8216, 03/2020, Volume 26, Issue 2, pp. 282 - 289
standard half‐life products | extended half‐life products | pharmacokinetic | rFVIII‐Fc | Life Sciences & Biomedicine | Hematology | Science & Technology | Pharmacokinetics | Patients | Clotting | Prophylaxis | Hemophilia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature
by Jeanpierre, Emmanuelle and Dubois, Romain and Carpentier, Benjamin and Lopez, Benjamin and Russick, Jules and Delignat, Sandrine and Sanges, SeBastien
Frontiers in immunology, ISSN 1664-3224, 12/2020, Volume 11
Medicine, Experimental | Medical research | Blood coagulation factor VIII | Immunoglobulin G | Hemophilia | anti-factor VIII autoantibodies | acquired hemophilia A | IgG4-related disease | plasma cell | IgG4 antibodies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma
by Perrin, Julien and Depasse, François and Lecompte, Thomas and CHU DIJON and CHU REIMS and Diagnostica Stago labs (N=3) and HUG, GENEVE, SWITZERLAND and AP-HP BICETRE and UCL, MONT-GODINNE, BELGIUM and CHU TOURS and AP-HP BICHAT / INSERM U698 and AP-HP HEGP and CHU ST ETIENNE and LABM DE LA BRUCHE and on behalf of French-speaking CAT group and under the aegis of GEHT and UNIVERSITE DE NAMUR, BELGIUM and CHU LILLE and AP-HP BEAUJON and AP-MARSEILLE LA TIMONE and Participating centres from the French-speaking CAT group (all in France unless otherwise stated) and AP-MARSEILLE LA CONCEPTION and CHU MONTPELLIER and CHU RENNES and AP-HP LARIBOISIERE and HOSPICES CIVILS DE LYON and CHU GRENOBLE and CHU BREST and CHU ROUEN and BIOMNIS and CHU LIEGE, BELGIUM and CHU NANCY and CHU BORDEAUX and CHU CLERMONT FERRAND and CHU NIMES and EFS ALSACE and CHU POITIERS and French-Speaking CAT Grp and Under Aegis GEHT and French-speaking CAT group and under the aegis of GEHT and French-speaking CAT group (all in France unless otherwise stated) and French-speaking CAT group all in France unless otherwise stated
Thrombosis research, ISSN 0049-3848, 2015, Volume 136, Issue 1, pp. 125 - 130
Hematology, Oncology and Palliative Medicine | Standardisation | Normalisation | Thrombin generation tests | Reference plasma | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Plasma - metabolism | Reference Standards | Reproducibility of Results | Humans | Blood Coagulation Tests - methods | Blood Coagulation Tests - standards | Calibration | Thrombin - metabolism | Surveys | Thrombin | Quality management | Index Medicus | Life Sciences | Human health and pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Multicentre evaluation of CK Prest® for assaying plasma levels of factor IX fused with albumin (Idelvion®)
by Pouplard, Claire and Galinat, Hubert and Ternisien, Catherine and Blanc Jouvan, Florence and De Maistre, Emmanuel and Duchemin, Jérôme and Flaujac, Claire and Hézard, Nathalie and Grand, François and Le Cam‐Duchez, Véronique and Marlu, Raphael and Mourey, Guillaume and Nedelec, Fabienne and Pineau‐Vincent, Fabienne and Repesse, Yohann and Stépanian, Alain and Szymezak, Jean and Voisin, Sophie and Voyer, Anne Lise and Jeanpierre, Emmanuelle and Lasne, Dominique and French Study Grp and Lab Management Bleeding Disorders and French Study Group on Laboratory Management of bleeding disorders (BIMHO group) and the French Study Group on Laboratory Management of bleeding disorders (BIMHO group)
Haemophilia : the official journal of the World Federation of Hemophilia, ISSN 1351-8216, 09/2019, Volume 25, Issue 5, pp. e327 - e330
Life Sciences & Biomedicine | Hematology | Science & Technology | Factor IX - metabolism | Humans | Serum Albumin, Human - metabolism | Coagulation factors | Plasma levels | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: Study protocol for a randomized controlled trial
by Ducloy-Bouthors, Anne-Sophie and Jeanpierre, Emmanuelle and Saidi, Imen and Baptiste, Anne-Sophie and Simon, Elodie and Lannoy, Damien and Duhamel, Alain and Allorge, Delphine and Susen, Sophie and Hennart, Benjamin
Trials, ISSN 1745-6215, 03/2018, Volume 19, Issue 1, pp. 149 - 149
D-dimers | Postpartum hemorrhage | Tranexamic acid | Pharmacokinetics | Fibrinolysis | Cesarean section | Plasmin | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Cesarean Section - adverse effects | Fibrinolysis - drug effects | Fibrin Fibrinogen Degradation Products - metabolism | Postpartum Hemorrhage - diagnosis | Humans | Antifibrinolytic Agents - adverse effects | Drug Monitoring - methods | Drug Dosage Calculations | Multicenter Studies as Topic | Time Factors | Antifibrinolytic Agents - administration & dosage | Preliminary Data | Female | France | Fibrinolysin - metabolism | Antifibrinolytic Agents - pharmacokinetics | Blood Loss, Surgical - prevention & control | Postpartum Hemorrhage - prevention & control | Double-Blind Method | Treatment Outcome | Biomarkers - blood | Postpartum Hemorrhage - blood | Tranexamic Acid - adverse effects | Randomized Controlled Trials as Topic | Pregnancy | Pilot Projects | Tranexamic Acid - pharmacokinetics | Tranexamic Acid - administration & dosage | Care and treatment | Postpartum depression | Dosage and administration | Health aspects | Index Medicus | Study Protocol
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Factor VIII and IX assays for post‐infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT)
by Jeanpierre, Emmanuelle and Pouplard, Claire and Lasne, Dominique and Le Cam Duchez, Véronique and Eschwege, Valérie and Flaujac, Claire and Galinat, Hubert and Harzallah, Ines and Proulle, Valérie and Smahi, Motalib and Sobas, Frédéric and Stepina, Nataliia and Toulon, Pierre and Voisin, Sophie and Ternisien, Catherine and Nougier, Christophe and Gelas, Martine Alhenc and Biron, Christine and Blanc‐Jouvan, Florence and Bourgerette, Evelyne and Bulabois, Benedicte and Comio, Emilie and Donnard, Magali and Duchemin, Jerôme and Faure, Anne‐Camille and Grand, François and Grunebaum, Lelia and Guicheteau, Maryse and Guerrero, Felipe and Hezard, Nathalie and Hurtaud, Marie‐Françoise and Nedelec Gac, Fabienne and De Maistre, Emmanuel and Marlu, Raphael and Mourey, Guillaume and Munier, Perrine and Pineau‐Vincent, Fabienne and Raffenot, Didier and Repesse, Yohan and Ryman, Anne and Sattler, Laurent and Sauguet, Pauline and Serre‐Sapin, Anne‐Francoise and Stepanian, Alain and Szymezak, Jean and Toussaint‐Hacquart, Marie and Tuffigo, Marie and Voyer, Annelise and French Study Grp Biology and French Study Group on the Biology of Hemorrhagic Diseases (the BIMHO group) and the French Study Group on the Biology of Hemorrhagic Diseases (the BIMHO group)
European journal of haematology, ISSN 0902-4441, 08/2020, Volume 105, Issue 2, pp. 103 - 115
haemophilia B | Factor IX | haemophilia A | chronometric and chromogenic assays | Factor VIII | Life Sciences & Biomedicine | Hematology | Science & Technology | Literature reviews | Coagulation factors | Factor VIII deficiency | Hemorrhage | Clotting | Hemophilia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights